-+ 0.00%
-+ 0.00%
-+ 0.00%

ASCENDIS ANNOUNCES ORAL PRESENTATION OF WEEK 104 DATA FROM ITS PIVOTAL TRIAL OF TRANSCON® CNP (NAVEPEGRITIDE) AT ISDS 2026

Reuters·08/25/2026 20:01:00

Please log in to view news